![Kevin Finney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Finney
Direktor/Vorstandsmitglied bei
VAXART, INC.
Vermögen: 110 979 $ am 30.06.2026
Profil
Kevin P.
Finney was the founder of Zavante Therapeutics, Inc., founded in 2015, where the title held was Chief Operating Officer from 2015 to 2018.
Current jobs include Chairman, President & Chief Executive Officer at Autobahn Therapeutics, Inc. since 2019; Vice Chairman at Eirion Therapeutics, Inc. since 2016; and Independent Director at Vaxart, Inc. starting in 2025.
Former jobs include Chairman at Elsie Biotechnologies Inc. from 2021 to 2024; Director at Anterios, Inc. from 2015 to 2016; Director at TARIS BioMedical LLC from 2015 to 2019; President, Chief Operating Officer & Director at Abide Therapeutics, Inc. in 2019; and Head-World Wide Corporate Development at Allergan, Inc. from 2006 to 2015.
Education includes undergraduate studies at The California State University and an MBA from Pepperdine Graziadio Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC. 0,08 % | 26.05.2026 | 183.437 ( 0,08 % ) | 110 979 $ | 30.06.2026 |
Aktive Positionen von Kevin Finney
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXART, INC. | Direktor/Vorstandsmitglied | 28.01.2025 |
Eirion Therapeutics, Inc.
 Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription products for medical dermatology and aesthetic medicine | Direktor/Vorstandsmitglied | 01.01.2016 |
Autobahn Therapeutics, Inc.
 Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Vorstandsvorsitzender | 01.11.2019 |
Ehemalige bekannte Positionen von Kevin Finney
| Unternehmen | Position | Ende |
|---|---|---|
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Vorsitzender | 01.06.2024 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Direktor/Vorstandsmitglied | 01.12.2019 |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Präsident | 01.07.2019 |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Gründer | 01.09.2018 |
Anterios, Inc.
 Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Direktor/Vorstandsmitglied | 01.01.2016 |
Ausbildung von Kevin Finney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription products for medical dermatology and aesthetic medicine | Health Technology |
Pepperdine Graziadio Business School
 Pepperdine Graziadio Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops medications for the treatment of central nervous system (CNS) disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
Wählen Sie MarketScreener 
